Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Invested Capital (2020 - 2025)

Journey Medical's Invested Capital history spans 6 years, with the latest figure at $31.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 29.14% year-over-year to $31.9 million, compared with a TTM value of $31.9 million through Dec 2025, down 29.14%, and an annual FY2025 reading of $31.9 million, down 29.14% over the prior year.
  • Invested Capital for Q4 2025 was $31.9 million at Journey Medical, up from $31.5 million in the prior quarter.
  • The five-year high for Invested Capital was $56.2 million in Q1 2022, with the low at -$11.7 million in Q3 2021.
  • Average Invested Capital over 5 years is $28.7 million, with a median of $30.9 million recorded in 2024.
  • Year-over-year, Invested Capital crashed 271.61% in 2021 and then skyrocketed 6361.99% in 2022.
  • Tracing DERM's Invested Capital over 5 years: stood at $42.9 million in 2021, then rose by 4.41% to $44.7 million in 2022, then decreased by 21.85% to $35.0 million in 2023, then grew by 28.53% to $44.9 million in 2024, then decreased by 29.14% to $31.9 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Invested Capital are $31.9 million (Q4 2025), $31.5 million (Q3 2025), and $23.0 million (Q2 2025).